Searchable abstracts of presentations at key conferences in endocrinology

Endocrine Abstracts

Published by BioScientifica
Previous issue | Volume 107 | IACS9 | Next issue

9th International Adrenal Cancer Symposium

Houston, USA
22 Nov 2024 - 23 Nov 2024

Card image cap
The 9th International Adrenal Cancer Symposium marks the latest installment in a series of successful global gatherings, with each previous event drawing an impressive assembly of 150-250 participants from across the world

9th International Adrenal Cancer Symposium 2024

Abstracts

Table of contents

ea0107001 | Abstracts

Cross-study reconciliation of SF-1 regulatory targets in adrenocortical carcinoma through in silico analysis

ea0107002 | Abstracts

Evaluating the response of immunotherapy in metastatic adrenocortical carcinoma – a single institution retrospective review

ea0107003 | Abstracts

Clinical presentation, management, and outcomes of patients with small (≤ 4 cm) adrenocortical carcinoma: single-center retrospective cohort study

ea0107004 | Abstracts

Circulating cell-free DNA for adrenal masses discrimination: a pilot study

ea0107005 | Abstracts

Outcome of combination chemotherapy for metastatic adrenocortical carcinoma

ea0107006 | Abstracts

Phase 2 study of monotherapy with pembrolizumab for advanced adrenocortical carcinoma

ea0107007 | Abstracts

Combination therapy of multi-targeted tyrosine kinase inhibitors and immune checkpoint inhibitors for advanced adrenocortical carcinoma

ea0107008 | Abstracts

Clinical and genetic characteristics of patients with adrenocortical carcinoma and lynch syndrome

ea0107009 | Abstracts

Characterizing the biology of ACC by longitudinal dual-PET imaging and multi-omics analyses

ea0107010 | Abstracts

Dual inhibition of PLK1 and multiple CDKs: a novel approach for the treatment of adrenocortical carcinomas

ea0107011 | Abstracts

In vivo CRISPR screening identifies tada2b as a key epigenetic regulator of immune response in adrenocortical carcinoma

ea0107012 | Abstracts

PCDHGC3 hypermethylation as a diagnostic and prognostic biomarker in adrenocortical carcinomas

ea0107013 | Abstracts

Discovery and characterization of OR-449, a potent antagonist to steroidogenic factor-1 (SF-1) and clinical candidate for treatment of ACC

ea0107014 | Abstracts

Silent adrenal neoplasm masquerading as adrenocortical carcinoma in a patient with neurofibromatosis type 1

ea0107015 | Abstracts

Bone metastasis model for the interrogation of ACC progression and therapeutic response: lessons learned from genitourinary cancers

ea0107016 | Abstracts

Chloroquine inhibits adrenocortical carcinoma cell survival independent of its effects on autophagy

ea0107017 | Abstracts

Practice patterns, characteristics, and clinical outcomes for patients with ACC referred to a tertiary academic medical center

ea0107018 | Abstracts

Bilateral adrenal carcinoma: a rare case report

Published by BioScientifica

Endocrine Abstracts
ISSN 1470-3947 (print) | ISSN 1479-6848 (online)
© Bioscientifica 2025 | Privacy policy | Cookie settings

BiosciAbstracts

Bioscientifica Abstracts is the gateway to a series of products that provide a permanent, citable record of abstracts for biomedical and life science conferences.

Find out more